Clinical trial
Mechanisms of Alcohol Sensitivity in Aspirin Exacerbated Respiratory Disease
NCT03441438 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanisms of Alcohol Sensitivity in Aspirin Exacerbated Respiratory Disease
- Lead sponsor
- University of Virginia
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- May 1, 2018
- Completion date
- September 1, 2018
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aspirin-sensitive asthma with nasal polyps, samter's syndrome